{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02196831","recordId":"NCT02196831","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02196831-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02196831.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02196831.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-07-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2014-07-21","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"5299cdd2724b5604359d8a018327174b4b1c034ffa6839bf19f35005c7578a6a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-07-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2014-07-22","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"e85bf6cfe45407434bd41789982f2b9448f7fdda9393bb7bbaa8614539018dc9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-10-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2014-10-14","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"3568932e42b915078affe8a488ee674cd8332357980425619431162c72f25eca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-02-18","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"95c06aa77b4751d92e57ac318d6f6c35caf38a06900c0654d4b25809bab42f61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Oversight","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2015-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-07-16","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"b56190243fdac7ec6a7c2846094f555d60b30fec4b286432e86a548280aa7c61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2015-10-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2015-10-28","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"55cc7a4380ef210c57c7c2941b161c97ac0dcca33cb5083f88bbfdae845cc893","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-03-14","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"0952999c1188b9abffd1f2424c5b45b450e1fe2182b7312975e3afc121711b29","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2016-08-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2016-08-19","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"1021acb14b218e9a75d8aa09359f7686b93e6b5b355ee42c3f77f45694365eda","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2017-08-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2017-08-28","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"ea197453e41eae96ea4655088bd032d4dea31f570f03cc7e9e7a644a6a08dc5f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2018-02-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-02-03","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"a80087d13f24637633eff6a5b5456a572ccc284f5ca27a03219812cba6761f15","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2018-10-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2018-10-19","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"5ca2ed070a4c79120b6ded802ab120226aa346d62016821938f40b94ab3f510f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2019-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2019-12-19","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"02f4496c4b1afc021f348f0ebe1530845abd67853814d93caefce56f1380045c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2020-01-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2020-01-13","publishedAt":"2026-08-23","recordId":"NCT02196831","recordSha256":"f2094e86e64d287b5ee185df577baf02a7383d61e3cf75e055e540727fae60b4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02196831?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"c11c7374b51dde0961c147886307e1434840c49015f6274219d16216cdc19179"}}